#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Exclusive enteral nutrition –  first-line therapy of Crohn’s disease in children


Authors: E. Karásková
Authors place of work: Dětská klinika LF UP a FN Olomouc
Published in the journal: Gastroent Hepatol 2015; 69(6): 531-535
Category: Dětská gastroenterologie a hepatologie: přehledová práce
doi: https://doi.org/10.14735/amgh2015531

Summary

Inflammatory bowel diseases include Crohn‘s disease and ulcerative colitis. Up to 20% of patients with Crohn’s disease are diagnosed before the age of 18 years. The onset of the disease in childhood is often accompanied by growth retardation and impaired bone metabolism. The therapeutic approach differs in certain aspects from the treatment of adult patients. Particularly, exclusive enteral nutrition is recommended as first-line therapy to induce remission in children with newly diagnosed Crohn’s disease. Over recent years this therapy has often replaced corticosteroids. According to available studies, this treatment induces endoscopic remission better than corticosteroids, while improving bone metabolism, growth and nutritional status. Exclusive enteral nutrition is generally well tolerated and with proper administration its complications and side effects areminimal.

Key words:
Crohn’s disease – child – enteral nutrition

The author declares he has no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for bio­­­­medical papers.

 Submitted:
21. 10. 2015

 Accepted:
6. 11. 2015


Zdroje

1. Ruem­mele FM, Veres G, Kolho KL et al. Consensus guidelines of ECCO/ ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis 2014; 8(10): 1179– 1207. doi: 10.1016/ j.crohns.2014.04.005.

2. Bousvaros A. Use of im­munomodulators and bio­logic therapies in children with inflam­matory bowel disease. Expert Rev Clin Im­munol 2010; 6(4): 659– 666. doi: 10.1586/ eci.10.46.

3. Pigneur B, Seksik P, Viola S et al. Natural history of Crohn’s disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis 2010; 16(6): 953– 961. doi: 10.1002/ ibd.21152.

4. Navas-López VM, Blasco-Alonso J, Lacasa Maseri S et al. Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn’s disease in the era of bio­logics. An Pediatr (Barc) 2015; 83(1): 47– 54. doi: 10.1016/ j.anpedi.2014.02.027.

5. Zachos M, Tondeur M, Grif­fiths AM. Enteral nutritional therapy for induction of remis­sion in Crohn’s disease. Cochrane Database Syst Rev 2007; 1: CD000542.

6. Kansal S, Wagner J, Kirkwood CD et al. Enteral nutrition in Crohn’s disease: an underused therapy. Gastroenterol Res Pract 2013; 2013: 482108. doi: 10.1155/ 2013/ 482108.

7. Cameron FL, Gerasimidis K, Papangelou A et al. Clinical progress in the two years fol­low­ing a course of exclusive enteral nutrition in 109 paediatric patients with Crohn’s disease. Aliment Pharmacol Ther 2013; 37(6): 622– 629. doi: 10.1111/ apt.12230.

8. Soo J, Malik BA, Turner JM et al. Use of exclusive enteral nutrition is just as ef­fective as corticosteroids in newly dia­gnosed pediatric Crohn’s disease. Dig Dis Sci 2013; 58(12): 3584– 3591. doi: 10.1007/ s10620-013-2855-y.

9. Sanderson IR, Udeen S, Davies PS et al. Remis­sion induced by an elemental diet in small bowel Crohn’s disease. Arch Dis Child 1987; 62(2): 123– 127.

10. González-Huix F, de León R, Fernández-Bañares F et al. Polymeric enteral diets as primary treatment of active Crohn’s dis­ease: a prospective steroid control­led trial. Gut 1993; 34(6): 778– 782.

11. Kaakoush NO, Day AS, Leach ST et al. Ef­fect of exclusive enteral nutrition on the microbio­ta of children with newly dia­gnosed Crohn’s disease. Clin Transl Gastroenterol 2015; 6:e71. doi: 10.1038/ ctg.2014.21.

12. Lee D, Albenberg L, Compher C et al. Diet in the pathogenesis and treatment of inflam­matory bowel diseases. Gastroenterology 2015; 148(6): 1087– 1106. doi: 10.1053/ j.gastro.2015.01.007.

13. Ruuska T, Savilahti E, Mäki M et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 1994; 19(2): 175– 180.

14. Bor­rel­li O, Cordischi L, Cirul­li M et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized control­led open-label trial. Clin Gastroenterol Hepatol 2006; 4(6): 744– 753.

15. Lee D, Baldas­sano RN, Otley AR el al. Comparative Ef­fectiveness of Nutritional and Biological Therapy in North Ame-rican Children with Active Crohn’s Dis-ease. Inflamm Bowel Dis 2015; 21(8): 1786– 1793. doi: 10.1097/ MIB.0000000000000426.

16. Ludvigs­son JF, Krantz M, Bodin L et al. Elemental versus polymeric enteral nutrition in paediatric Crohn’s disease: a multicentre randomized control­led trial. Acta Paediatr 2004; 93(3): 327– 335.

17. Adamcová M, Bajer M, Bajerová K et al. Doporučení Pracovní skupiny dětské gastroenterologie a výživy ČPS pro dia­gnostiku a léčbu nespecifických střevních zánětů u dětí. Čes Slov Pediat 2012; 67 (Suppl 2): 4– 48.

18. Esaki M, Matsumoto T, Nakamura S et al.Factors af­fect­ing recur­rence in patients with Crohn’s disease under nutritional therapy. Dis Colon Rectum 2006; 49 (Suppl 10): S68– S74.

19. Karásková E, Vydra D, Smolka V et al. Refeed­ing syndrom v dětském věku. Čes-slov Pediat 2014; 69(6): 363– 369.

Štítky
Detská gastroenterológia Gastroenterológia a hepatológia Chirurgia všeobecná

Článok vyšiel v časopise

Gastroenterologie a hepatologie

Číslo 6

2015 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#